Skip to content

Effect of ciprofol-fentanyl on painless hysteroscopic surgery

Effect of ciprofol-fentanyl on painless hysteroscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067717
Enrollment
Unknown
Registered
2023-01-19
Start date
2023-01-19
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopic surgery

Interventions

Group C:Induction and maintenance of ciprofol-fentanyl
Group P:Propofol-fentanyl induction and maintenance

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-65 years were selected for elective hysteroscopic surgery under non-intubated general anesthesia and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergy or contraindication to opioids, propofol, etc.; 2. Severe cardiovascular disease; 3. Severe respiratory disease; 4. The modified Mallampati was classified as grade IV; 5. Severe hepatic and renal insufficiency; 6. Suffering from mental illness or taking antipsychotic medications; 7. ASA >= IV, history of drug abuse, history of drug abuse, history of alcohol abuse; 8. Patients who participated in other clinical studies at the same time did not belong to this study.

Design outcomes

Primary

MeasureTime frame
Induction time;Recovery time;Injection pain;Circulatory inhibition;Respiratory Depression;

Secondary

MeasureTime frame
Adverse reactions;

Countries

China

Contacts

Public ContactChen Jing

The First Affiliated Hospital of Guangxi Medical University

352880721@qq.com+86 13607815280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026